AU2001257427A1 - Rna metabolism proteins - Google Patents

Rna metabolism proteins

Info

Publication number
AU2001257427A1
AU2001257427A1 AU2001257427A AU5742701A AU2001257427A1 AU 2001257427 A1 AU2001257427 A1 AU 2001257427A1 AU 2001257427 A AU2001257427 A AU 2001257427A AU 5742701 A AU5742701 A AU 5742701A AU 2001257427 A1 AU2001257427 A1 AU 2001257427A1
Authority
AU
Australia
Prior art keywords
rna metabolism
metabolism proteins
proteins
rna
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257427A
Inventor
Janice Au-Young
Yalda Azimzai
Sajeev Batra
Mariah R. Baughn
Neil Burford
Jennifer L. Hillman
Preeti Lal
Dyung Aina M. Lu
Jennifer J. Policky
Y. Tom Tang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001257427A1 publication Critical patent/AU2001257427A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001257427A 2000-04-28 2001-04-27 Rna metabolism proteins Abandoned AU2001257427A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US20018400P 2000-04-28 2000-04-28
US60200184 2000-04-28
US20209000P 2000-05-04 2000-05-04
US20187500P 2000-05-04 2000-05-04
US60201875 2000-05-04
US60202090 2000-05-04
US21023200P 2000-06-06 2000-06-06
US60210232 2000-06-06
US22055300P 2000-07-25 2000-07-25
US60220553 2000-07-25
PCT/US2001/013862 WO2001083524A2 (en) 2000-04-28 2001-04-27 Rna metabolism proteins

Publications (1)

Publication Number Publication Date
AU2001257427A1 true AU2001257427A1 (en) 2001-11-12

Family

ID=27539426

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257427A Abandoned AU2001257427A1 (en) 2000-04-28 2001-04-27 Rna metabolism proteins

Country Status (5)

Country Link
EP (1) EP1278843A2 (en)
JP (1) JP2004511208A (en)
AU (1) AU2001257427A1 (en)
CA (1) CA2407435A1 (en)
WO (1) WO2001083524A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
WO2002029057A2 (en) * 2000-10-05 2002-04-11 Millenium Pharmaceuticals, Inc. 32144, a human fatty acid amide hydrolase and uses thereof
US7074576B2 (en) * 2001-11-23 2006-07-11 Syn X Pharma, Inc. Protein biopolymer markers indicative of alzheimer's disease
US7179606B2 (en) * 2001-11-23 2007-02-20 Syn X Pharma, Inc. IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
WO2013024467A2 (en) * 2011-08-18 2013-02-21 Ecole Polytechnique Federale De Lausanne (Epfl) Mitochondrial ribosomal proteins as aging regulators
US11161874B2 (en) * 2016-08-19 2021-11-02 Genoimmune Therapeutics Co., Ltd. Tumor-specific polypeptide and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962226A (en) * 1996-11-26 1999-10-05 Incyte Pharmaceuticals, Inc. Human RNA-binding protein
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2004507202A (en) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション Nucleic acid containing an open reading frame encoding a polypeptide; "ORFX"
WO2001087917A1 (en) * 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
CA2407435A1 (en) 2001-11-08
JP2004511208A (en) 2004-04-15
WO2001083524A2 (en) 2001-11-08
EP1278843A2 (en) 2003-01-29
WO2001083524A3 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001242625A1 (en) Gene sequence
AU2001269888A1 (en) Protein phosphatases
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2001264247A1 (en) GASC1 gene
AU2001283012A1 (en) Protein phosphatases
AU2001257427A1 (en) Rna metabolism proteins
AU2001292870A1 (en) Protein phosphatases
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001285743A1 (en) Adipose-related gene
AU2002216100A1 (en) Dormancy - induced mycobacterium proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001284265A1 (en) Genetic study
AUPR968801A0 (en) Improvements in enzyme stability
AU2002326641A1 (en) Nucleic-acid associated proteins
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU5494700A (en) Rna metabolism proteins
AU2001241044A1 (en) Mitf-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU2001263445A1 (en) Methods for protein design
AU2001261039A1 (en) Protein phosphatases
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2002229561A1 (en) Fluorescent proteins
AU2001277614A1 (en) Novel proteins
AU2002210985A1 (en) Pca2501 gene